SLC5A2 and type 2 diabetes mellitus: Compared with T2DM patients on non-SGLT2 inhibitors, there was no difference in PR interval, QT interval, ST-T changes, bundle-branch block, or ventricular arrhythmia in the patients on SGLT2 inhibitors.